Eculizumab in the treatment of atypical haemolytic uraemic syndrome and other complement-mediated renal diseases.

Eculizumab in the treatment of atypical haemolytic uraemic syndrome and other complement-mediated renal diseases.

Item
http://www.wikidata.org/entity/Q33406434
Complement cascade and kidney transplantation: The rediscovery of an ancient enemyDiagnosis and management of thrombotic microangiopathy: the role of registries.Complement Factor C4d Is a Common Denominator in Thrombotic Microangiopathy.Complement in disease: a defence system turning offensiveMonitoring of complement activation biomarkers and eculizumab in complement-mediated renal disorders.Two cases of atypical hemolytic uremic syndrome (aHUS) and eosinophilic granulomatosis with polyangiitis (EGPA): a possible relationship.New milestones ahead in complement-targeted therapy.Molecular genetics of familial hematuric diseases.The Evolving Landscape for Complement Therapeutics in Rheumatic and Autoimmune Diseases.Local Inhibition of Complement Improves Mesenchymal Stem Cell Viability and Function After AdministrationSevere active C3 glomerulonephritis triggered by immune complexes and inactivated after eculizumab therapy.De novo glomerular diseases after renal transplantation: How is it different from recurrent glomerular diseases?Brain histopathology in patients with systemic lupus erythematosus: identification of lesions associated with clinical neuropsychiatric lupus syndromes and the role of complement.Eculizumab Prevents Recurrent Antiphospholipid Antibody Syndrome and Enables Successful Renal Transplantation
P2860

Eculizumab in the treatment of atypical haemolytic uraemic syndrome and other complement-mediated renal diseases.

Item
http://www.wikidata.org/entity/Q33406434
description
2013 nî lūn-bûn
@nan
2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Eculizumab in the treatment of ...... ement-mediated renal diseases.
@ast
Eculizumab in the treatment of ...... ement-mediated renal diseases.
@en
type
label
Eculizumab in the treatment of ...... ement-mediated renal diseases.
@ast
Eculizumab in the treatment of ...... ement-mediated renal diseases.
@en
prefLabel
Eculizumab in the treatment of ...... ement-mediated renal diseases.
@ast
Eculizumab in the treatment of ...... ement-mediated renal diseases.
@en
P1433
P1476
P2093
P304
P31
P356
P433
P478
P577
P698
P356
P1433
P1476
Eculizumab in the treatment of ...... ement-mediated renal diseases.
@en
P2093
P304
P31
P356
10.1097/MOP.0B013E32835DF4A3
P433
P478
P577
P698